COPD as a risk factor for Coronary Artery Disease (CAD): Overview of 10-year atherosclerotic cardiovascular disease (ASCVD) risk assessment

D. Buklioska Ilievska (Skopje, North Macedonia), J. Minov (Skopje, North Macedonia), N. Kochovska Kamchevska (Skopje, North Macedonia), I. Mickovski (Skopje, North Macedonia), T. Hasan (Skopje, North Macedonia), M. Baloski (Skopje, North Macedonia), R. Neshovska (Skopje, North Macedonia), N. Nedeska Minova (Skopje, North Macedonia), B. Prgova-Veljanova (Skopje, North Macedonia), D. Doneva (Skopje, North Macedonia), V. Trajkovska (Skopje, North Macedonia), M. Simeonova (Skopje, North Macedonia), J. Bushev (Skopje, North Macedonia)

Source: International Congress 2022 – COPD management: comorbidities, cohorts and real-world studies

Session: COPD management: comorbidities, cohorts and real-world studies
Session type: Thematic Poster
Number: 2111

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Buklioska Ilievska (Skopje, North Macedonia), J. Minov (Skopje, North Macedonia), N. Kochovska Kamchevska (Skopje, North Macedonia), I. Mickovski (Skopje, North Macedonia), T. Hasan (Skopje, North Macedonia), M. Baloski (Skopje, North Macedonia), R. Neshovska (Skopje, North Macedonia), N. Nedeska Minova (Skopje, North Macedonia), B. Prgova-Veljanova (Skopje, North Macedonia), D. Doneva (Skopje, North Macedonia), V. Trajkovska (Skopje, North Macedonia), M. Simeonova (Skopje, North Macedonia), J. Bushev (Skopje, North Macedonia). COPD as a risk factor for Coronary Artery Disease (CAD): Overview of 10-year atherosclerotic cardiovascular disease (ASCVD) risk assessment. 2111

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.